Belotecan for relapsing small-cell lung cancer patients initially treated with an irinotecan-containing chemotherapy: A phase II trialJEONG, Jaeheon; BYOUNG CHUL CHO; CHANG, Joon et al.Lung cancer. 2010, Vol 70, Num 1, pp 77-81, issn 0169-5002, 5 p.Article

A multicenter phase II study of belotecan, new camptothecin analogue, in patients with previously untreated extensive stage disease small cell lung cancerKIM, S. J; KIM, J. S; KIM, J. W et al.Lung cancer. 2010, Vol 68, Num 3, pp 446-449, issn 0169-5002, 4 p.Article

Phase II study of camtobell inj. (belotecan) in combination with cisplatin in patients with previously untreated, extensive stage small cell lung cancerLIM, Seungtaek; BYOUNG CHUL CHO; KIM, Darae et al.Lung cancer. 2013, Vol 80, Num 3, pp 313-318, issn 0169-5002, 6 p.Article

The Efficacy and Toxicity of Belotecan (CKD-602), a Camptothecin Analogue Topoisomerase I Inhibitor, in Patients with Recurrent or Refractory Epithelial Ovarian CancerKIM, Yong-Man; SHIN WHA LEE; KIM, Dae-Yeon et al.Journal of chemotherapy (Testo stampato). 2010, Vol 22, Num 3, pp 197-200, issn 1120-009X, 4 p.Article

CKD-602, a camptothecin derivative, inhibits proliferation and induces apoptosis in glioma cell linesKIM, Young-Yim; PARK, Chul-Kee; KIM, Seung-Ki et al.Oncology reports. 2009, Vol 21, Num 6, pp 1413-1419, issn 1021-335X, 7 p.Article

Multicenter Phase 2 Study of Belotecan, a New Camptothecin Analog, and Cisplatin for Chemotherapy-Naive Patients With Extensive-Disease Small Cell Lung CancerDAE HO LEE; KIM, Sang-We; SUNG HYUN YANG et al.Cancer. 2010, Vol 116, Num 1, pp 132-136, issn 0008-543X, 5 p.Article

Phase II study of combined belotecan and cisplatin as first-line chemotherapy in patients with extensive disease of small cell lung cancerHONG, Junshik; JUNG, Minkyu; DONG BOK SHIN et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 1, pp 215-220, issn 0344-5704, 6 p.Article